- Unité de Toxicologie Alimentaire - Dijon In vitro metabolism of DADS by rat and human subcellular fractions Results in rat presented Results in human.

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

Assignment 6 Metabolism
Pharmacokinetics Ampicillin Ceftriaxone Vancomycin Half-Life: hr
In vitro and in vivo metabolism of repaglinide: Modeling clinically- relevant drug-drug interactions Joanna Barbara, Ph.D. Director of Analytical Services,
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Advanced Medicinal Chemistry
Improving Candidate Quality Through the Prediction of Clinical Outcome.
Agnieszka Potęga, PhD 3 rd INTERNATIONAL SUMMIT ON TOXICOLOGY & APPLIED PHARMACOLOGY Chicago, USA, October 20 – 22, 2014 Department of Pharmaceutical Technology.
Marie-Hélène SIESS et al.
Metabolism of Xenobiotics I. General Overview Aug 25, 2011 L.M. Ball Rosenau 158 ENVR/TOXC 442 Fall 2011.
Metabolite Kinetics II
Body clear- 1 Body clearance OCT 2010 PL Toutain.
Laplace transformation
Practical Pharmacokinetics
November 2007 Metabolite Kinetics Theoretical Approach PHM324Y Guest Lecturer Dr. Jasmina Novakovic Apotex Inc, R&D.
WP 6 UMR de Toxicologie Alimentaire INRA Dijon WP 6 Cancer : General objectives  inhibition of bio-activation of carcinogens  stimulation of detoxification.
WP 6 UMR de Toxicologie Alimentaire INRA Dijon WP 6 Cancer : General objectives  inhibition of bio-activation of carcinogens  stimulation of detoxification.
1 Discovering new drugs in Africa Defeating Malaria Together Kelly Chibale PhD FRSSAf University of Cape Town.
Species extrapolation with PBPK models
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Sulindac Pharmacokinetics
Garlic & Health Health Part University of Leipzig.
RESEARCH Lymphatic Targeting of Tenofovir; Intracellular Pharmacokinetics and Viral Dynamics Arnold Fridland, Ph.D, William Lee, Ph.D. Gilead Sciences,
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Main Topics of Research in the Health Part Effects of garlic powders and known compounds on cellular functions related to arteriosclerosis or inflammation.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Atelier PK sur articles. 5 thèmes Absorption / biodisponibilité Métabolisme hépatique et effet de premier passage Les modèles in vitro d’étude de l’absorption.
EVALUATION OF THE ANTIGENOTOXIC POTENTIAL OF GARLIC SULFUR COMPOUNDS IN HEPG2 CELLS C. Belloir, M.H. Siess, C. Daurat and A.M. Le Bon INRA, UMR Toxicologie.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
WP 6 UMR de Toxicologie Alimentaire INRA WP6 : Effects of garlic on carcinogen metabolizing enzymes Milestones :  In vitro effects of garlic compounds.
Continuous intravenous infusion (one-compartment model)
Protection of garlic against carcinogen genotoxicity Anne-Marie Le Bon, Christine Belloir, Varsha Singh Milestones :  In vitro evaluation of the antigenotoxic.
Plasma Protein Binding
Simultaneous evaluation of the activity of five cytochrome P450 enzymes by a cocktail study in healthy volunteers Department of Pharmacy Practice & Sciences.
Metabolic Stability Lee, Sang-Hwi. -2- Overview Metabolism is the enzymatic modification of compounds to increase clearance. It is a determinant.
The studied molecules are : Range : 5 to 100 µMDADS (diallyl sulfide) DADSO (allicin) SAC (S-allyl cystein) AM (allyl mercaptan) Anti-genotoxicity studies.
Drug Transfer into Milk: Clinical Methods & Issues Patrick J. McNamara University of Kentucky College of Pharmacy College of Pharmacy.
GARLIC AND HEALTH in vivo Metabolism of DADS 4 th October 2001 Study of in vivo Diallyl disulfide Metabolism Aims of the study : –To determine the pharmacokinetic.
Lee,Sang-Hwi Pharmacokinetics (PK). Overview Pharmacokinetics (PK) studies the concentration time course of compounds and metabolites in.
Clearance: basic concept (in vitro) Update OCT 2010.
Metabolism Chemical transformaion of xenobiotics Occurs in mostly in liver (enzymatic prosesses) Convertion into more hydrophil. subst. - excretion urine.
Emmanuelle Germain, Joelle Chevalier, Marlène Steib, Marie-Hélène Siess* and Caroline Teyssier* Institut National de la Recherche Agronomique / ENSBANA,
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
Formation of Hydroxylated Compounds by Microsomal Metabolism of 2,2’,3,3’,6,6’-Hexachlorobiphenyl (PCB-136) Ananya Pramanik, Izabela Kania-Korwel, Jarline.
Allie punke Pharmacokinetics tutoring Fall 2016
Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4- aminoquinoline anti-malarials  Charles B. Davis, Ramesh Bambal, Ganesh.
Novel Transcription Factor Inhibitor as Treatment for Epithelial Cell Cancers John Bushweller, Department of Molecular Physiology and Biological Physics,
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetics of Old and New Glycopeptides
Lecture-8 Biopharmaceutics
Allie punke Pharmacokinetics tutoring Fall 2016
Isotope production Nuclear reactions t1/2 18F (p,n) 110 min
Protein in Basolateral Fluid (BSA) Cell Thickness/Diameter
Identification & Assessment of NPS: an European Network
Volume 44, Issue 6, Pages (June 2006)
Plasma Clearance.
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M6
Total ion current-EMS chromatograms of SB939 and its metabolites after incubation in liver microsomal fractions for 60 min at a concentration of 50 μM.
LIMITATIONS OF CYTOTOXICITY assays
Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children  N.J. Bouwmeester, B.J. Anderson, D Tibboel, N.H.G.
Xenobiotic or Drug Metabolism
Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1  Chun Liu, Robert M. Russell, Helmut.
Induction of Selected Lipid Metabolic Enzymes and Differentiation-Linked Structural Proteins by Air Exposure in Fetal Rat Skin Explants  László G. Kömüves,
Halothane enhances dopamine metabolism at presynaptic sites in a calcium- independent manner in rat striatum  Y.U. Adachi, M. Satomoto, H. Higuchi, K.
Volume 73, Issue 11, Pages (June 2008)
Covariates of tramadol disposition in the first months of life
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Therapeutic Drug Monitoring
unbound concentration µM
Presentation transcript:

- Unité de Toxicologie Alimentaire - Dijon In vitro metabolism of DADS by rat and human subcellular fractions Results in rat presented Results in human similar with the same metabolites

- Unité de Toxicologie Alimentaire - Dijon cofactors DADS HPLC-UV microsomes cytosols In vitro metabolism of DADS in rat ultracentrifugation subcellular fractions

- Unité de Toxicologie Alimentaire - Dijon DADS CYP 2B1/2 CYP 2E1 FMO AGS allyl glutathionyl sulfide AM allyl mercaptan GST DADSO

- Unité de Toxicologie Alimentaire - Dijon DADSO Km nmole Vmax nmol/min/mg prt Vmax/Km AGS + AM products  DADS  DADSO DADSO monooxigenase nmol/min/mg prt GST nmol/min/mg prt monooxygenase + GST nmol/min/mg prt AGS products AM 1.82 ± ± ± ± ± 0.01n.d.  DADS  DADSO + AM + AGS 0.86 ± ± ± ±

- Unité de Toxicologie Alimentaire - Dijon Isolated rat perfused liver livercollected bile

- Unité de Toxicologie Alimentaire - Dijon Single dose pharmacokinetic parameters for DADS in an isolated perfused rat liver. kel (min-1) 0.13 ± 0.03 AUC0-  (min.mmol/l) 4.77 ± 0.80 t1/2 (min) 6.09 ± 1.26 Clearance (ml/min)34.22 ± 5.6 Volume of distribution (ml)311.9 ± 0.08

- Unité de Toxicologie Alimentaire - Dijon Total Ionic Current chromatogram of the extract of liver, perfused with DADS, obtained on GC-MS.

- Unité de Toxicologie Alimentaire - Dijon GST DADS AGS allyl glutathionyl sulfide AM allyl mercaptan AMS allyl methyl sulfide CYP 2B1/2 CYP 2E1 FMO AMSO2 allyl methyl sulfone AMSO allyl methyl sulfoxide DADSO Compounds obtained in presence of subcellular fractions Compounds obtained in an isolated perfused liver MT

- Unité de Toxicologie Alimentaire - Dijon DADS: short half live time many metabolites  Which is the real active molecule in vivo ?